{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,13]],"date-time":"2026-09-13T03:11:34Z","timestamp":1789269094602,"version":"build-2803163510"},"reference-count":37,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,14]],"date-time":"2022-10-14T00:00:00Z","timestamp":1665705600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100013995","name":"Sanofi Genzyme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013995","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["gimjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Genetics in Medicine"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.gim.2022.10.005","type":"journal-article","created":{"date-parts":[[2022,11,17]],"date-time":"2022-11-17T20:45:54Z","timestamp":1668717954000},"page":"27-36","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"title":["Evaluating brain white matter hyperintensity, IQ scores, and plasma neurofilament light chain concentration in early-treated patients with infantile-onset Pompe disease"],"prefix":"10.1016","volume":"25","author":[{"given":"Yu-Kang","family":"Hsu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yin-Hsiu","family":"Chien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Shinn-Forng Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wuh-Liang","family":"Hwu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wang-Tso","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ni-Chung","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Po-Yu Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6923-9138","authenticated-orcid":false,"given":"Wen-Chin","family":"Weng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.gim.2022.10.005_bib1","series-title":"The Metabolic and Molecular Bases of Inherited Disease","first-page":"3389","article-title":"Glycogen storage disease type II: acid alpha-glucosidase (acid maltase) deficiency","author":"Hirschhorm","year":"2001"},{"issue":"2","key":"10.1016\/j.gim.2022.10.005_bib2","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1542\/peds.112.2.332","article-title":"The natural course of infantile Pompe\u2019s disease: 20 original cases compared with 133 cases from the literature","volume":"112","author":"van den Hout","year":"2003","journal-title":"Pediatrics"},{"issue":"2","key":"10.1016\/j.gim.2022.10.005_bib3","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1212\/01.wnl.0000251268.41188.04","article-title":"Recombinant human acid [alpha]-glucosidase: major clinical benefits in infantile-onset Pompe disease","volume":"68","author":"Kishnani","year":"2007","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.gim.2022.10.005_bib4","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.jpeds.2009.03.015","article-title":"Reversal of cardiac dysfunction after enzyme replacement in patients with infantile-onset Pompe disease","volume":"155","author":"Chen","year":"2009","journal-title":"J\u00a0Pediatr"},{"issue":"4","key":"10.1016\/j.gim.2022.10.005_bib5","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.pedneo.2013.03.009","article-title":"Pompe disease: early diagnosis and early treatment make a difference","volume":"54","author":"Chien","year":"2013","journal-title":"Pediatr Neonatol"},{"issue":"6","key":"10.1016\/j.gim.2022.10.005_bib6","doi-asserted-by":"crossref","first-page":"e1116","DOI":"10.1542\/peds.2008-3667","article-title":"Pompe disease in infants: improving the prognosis by newborn screening and early treatment","volume":"124","author":"Chien","year":"2009","journal-title":"Pediatrics"},{"issue":"13","key":"10.1016\/j.gim.2022.10.005_bib7","doi-asserted-by":"crossref","first-page":"289","DOI":"10.21037\/atm.2019.04.49","article-title":"An emerging phenotype of central nervous system involvement in Pompe disease: from bench to bedside and beyond","volume":"7","author":"Korlimarla","year":"2019","journal-title":"Ann Transl Med"},{"issue":"3","key":"10.1016\/j.gim.2022.10.005_bib8","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1203\/01.pdr.0000233014.84318.4e","article-title":"Brain development in infantile-onset Pompe disease treated by enzyme replacement therapy","volume":"60","author":"Chien","year":"2006","journal-title":"Pediatr Res"},{"issue":"4","key":"10.1016\/j.gim.2022.10.005_bib9","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/j.jpeds.2014.10.068","article-title":"Long-term prognosis of patients with infantile-onset Pompe disease diagnosed by newborn screening and treated since birth","volume":"166","author":"Chien","year":"2015","journal-title":"J\u00a0Pediatr"},{"issue":"12","key":"10.1016\/j.gim.2022.10.005_bib10","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1038\/labinvest.3700484","article-title":"Characterization of pre- and post-treatment pathology after enzyme replacement therapy for Pompe disease","volume":"86","author":"Thurberg","year":"2006","journal-title":"Lab Invest"},{"key":"10.1016\/j.gim.2022.10.005_bib11","first-page":"45","article-title":"Postmortem findings and clinical correlates in individuals with infantile-onset Pompe disease","volume":"23","author":"Pena","year":"2015","journal-title":"JIMD Rep"},{"issue":"1","key":"10.1016\/j.gim.2022.10.005_bib12","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/gim.2011.4","article-title":"Successful immune tolerance induction to enzyme replacement therapy in CRIM-negative infantile Pompe disease","volume":"14","author":"Messinger","year":"2012","journal-title":"Genet Med"},{"issue":"2","key":"10.1016\/j.gim.2022.10.005_bib13","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.ymgme.2017.10.005","article-title":"Neuroimaging findings in infantile Pompe patients treated with enzyme replacement therapy","volume":"123","author":"McIntosh","year":"2018","journal-title":"Mol Genet Metab"},{"issue":"6","key":"10.1016\/j.gim.2022.10.005_bib14","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1111\/dmcn.13740","article-title":"Classic infantile Pompe patients approaching adulthood: a cohort study on consequences for the brain","volume":"60","author":"Ebbink","year":"2018","journal-title":"Dev Med Child Neurol"},{"issue":"6","key":"10.1016\/j.gim.2022.10.005_bib15","doi-asserted-by":"crossref","first-page":"e718","DOI":"10.1212\/WNL.0000000000009979","article-title":"Novel approaches to quantify CNS involvement in children with Pompe disease","volume":"95","author":"Korlimarla","year":"2020","journal-title":"Neurology"},{"issue":"13","key":"10.1016\/j.gim.2022.10.005_bib16","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1212\/WNL.0000000000002523","article-title":"Cognitive decline in classic infantile Pompe disease: an underacknowledged challenge","volume":"86","author":"Ebbink","year":"2016","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.gim.2022.10.005_bib17","article-title":"Ultrastructural and diffusion tensor imaging studies reveal axon abnormalities in Pompe disease mice","volume":"10","author":"Lee","year":"2020","journal-title":"Sci Rep"},{"issue":"8","key":"10.1016\/j.gim.2022.10.005_bib18","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1136\/jnnp-2018-320106","article-title":"Neurofilament light chain as a biomarker in neurological disorders","volume":"90","author":"Gaetani","year":"2019","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"issue":"1","key":"10.1016\/j.gim.2022.10.005_bib19","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s12035-008-8033-0","article-title":"Review of the multiple aspects of neurofilament functions, and their possible contribution to neurodegeneration","volume":"38","author":"Perrot","year":"2008","journal-title":"Mol Neurobiol"},{"issue":"6","key":"10.1016\/j.gim.2022.10.005_bib20","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1002\/ana.24954","article-title":"Serum neurofilament light: a biomarker of neuronal damage in multiple sclerosis","volume":"81","author":"Disanto","year":"2017","journal-title":"Ann Neurol"},{"issue":"1","key":"10.1016\/j.gim.2022.10.005_bib21","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1093\/brain\/awab304","article-title":"Neurofilament light chain and glial fibrillary acidic protein levels in metachromatic leukodystrophy","volume":"145","author":"Beerepoot","year":"2022","journal-title":"Brain"},{"issue":"1","key":"10.1016\/j.gim.2022.10.005_bib22","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/s13195-018-0439-y","article-title":"Serum neurofilament light levels correlate with severity measures and neurodegeneration markers in autosomal dominant Alzheimer\u2019s disease","volume":"10","author":"S\u00e1nchez-Valle","year":"2018","journal-title":"Alzheimers Res Ther"},{"issue":"10","key":"10.1016\/j.gim.2022.10.005_bib23","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.3174\/ajnr.A1739","article-title":"Metachromatic leukodystrophy: a scoring system for brain MR imaging observations","volume":"30","author":"Eichler","year":"2009","journal-title":"AJNR Am J Neuroradiol"},{"key":"10.1016\/j.gim.2022.10.005_bib24","article-title":"Earlier and higher dosing of alglucosidase alfa improve outcomes in patients with infantile-onset Pompe disease: evidence from real-world experiences","volume":"23","author":"Chien","year":"2020","journal-title":"Mol Genet Metab Rep"},{"issue":"3","key":"10.1016\/j.gim.2022.10.005_bib25","doi-asserted-by":"crossref","first-page":"205","DOI":"10.4015\/S1016237211002591","article-title":"Cerebral diffusion tensor images in infants and neonates with infantile onset Pompe disease","volume":"23","author":"Peng","year":"2011","journal-title":"Biomed Eng - Appl Basis Commun"},{"issue":"5","key":"10.1016\/j.gim.2022.10.005_bib26","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1002\/ana.25467","article-title":"Gene therapy improves brain white matter in aromatic L-amino acid decarboxylase deficiency","volume":"85","author":"Tseng","year":"2019","journal-title":"Ann Neurol"},{"issue":"10","key":"10.1016\/j.gim.2022.10.005_bib27","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1515\/cclm-2015-1195","article-title":"Comparison of three analytical platforms for quantification of the neurofilament light chain in blood samples: ELISA, electrochemiluminescence immunoassay and Simoa","volume":"54","author":"Kuhle","year":"2016","journal-title":"Clin Chem Lab Med"},{"issue":"8","key":"10.1016\/j.gim.2022.10.005_bib28","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1097\/NEN.0b013e3181815994","article-title":"Temporal neuropathologic and behavioral phenotype of 6neo\/6neo Pompe disease mice","volume":"67","author":"Sidman","year":"2008","journal-title":"J\u00a0Neuropathol Exp Neurol"},{"issue":"1","key":"10.1016\/j.gim.2022.10.005_bib29","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.acra.2011.09.008","article-title":"A\u00a0semi-automatic algorithm for determining the demyelination load in metachromatic leukodystrophy","volume":"19","author":"Clas","year":"2012","journal-title":"Acad Radiol"},{"key":"10.1016\/j.gim.2022.10.005_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuroimage.2019.116327","article-title":"White matter hyperintensities and their relationship to cognition: effects of segmentation algorithm","volume":"206","author":"Tubi","year":"2020","journal-title":"Neuroimage"},{"key":"10.1016\/j.gim.2022.10.005_bib31","first-page":"55","article-title":"Rapidly progressive white matter involvement in early childhood: the expanding phenotype of infantile onset Pompe?","volume":"39","author":"Broomfield","year":"2018","journal-title":"JIMD Rep"},{"issue":"6","key":"10.1016\/j.gim.2022.10.005_bib32","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1007\/s10545-010-9209-0","article-title":"CRIM-negative infantile Pompe disease: 42-month treatment outcome","volume":"33","author":"Rohrbach","year":"2010","journal-title":"J\u00a0Inherit Metab Dis"},{"issue":"7","key":"10.1016\/j.gim.2022.10.005_bib33","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1212\/WNL.0000000000006906","article-title":"Serum neurofilament light and prediction of multiple sclerosis in clinically isolated syndrome","volume":"92","author":"Zetterberg","year":"2019","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.gim.2022.10.005_bib34","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s12035-019-01698-3","article-title":"Neurofilament light chain as a biomarker, and correlation with magnetic resonance imaging in diagnosis of CNS-related disorders","volume":"57","author":"Alirezaei","year":"2020","journal-title":"Mol Neurobiol"},{"issue":"11","key":"10.1016\/j.gim.2022.10.005_bib35","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/j.nmd.2019.09.011","article-title":"Clinical features of Pompe disease with motor neuronopathy","volume":"29","author":"Tsai","year":"2019","journal-title":"Neuromuscul Disord"},{"issue":"2","key":"10.1016\/j.gim.2022.10.005_bib36","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1007\/s11065-010-9127-9","article-title":"White matter: organization and functional relevance","volume":"20","author":"Filley","year":"2010","journal-title":"Neuropsychol Rev"},{"issue":"4","key":"10.1016\/j.gim.2022.10.005_bib37","doi-asserted-by":"crossref","first-page":"234","DOI":"10.3174\/ng.1700048","article-title":"Subcortical U-fibers: signposts to the diagnosis of white matter disease","volume":"8","author":"Riley","year":"2018","journal-title":"Neurographics"}],"container-title":["Genetics in Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098360022009741?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098360022009741?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T01:55:13Z","timestamp":1761098113000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1098360022009741"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["S1098360022009741"],"URL":"https:\/\/doi.org\/10.1016\/j.gim.2022.10.005","relation":{},"ISSN":["1098-3600"],"issn-type":[{"value":"1098-3600","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluating brain white matter hyperintensity, IQ scores, and plasma neurofilament light chain concentration in early-treated patients with infantile-onset Pompe disease","name":"articletitle","label":"Article Title"},{"value":"Genetics in Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gim.2022.10.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier Inc. on behalf of American College of Medical Genetics and Genomics.","name":"copyright","label":"Copyright"}]}}